Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04499781 · ClinicalTrials.gov registry record · NA

Adherence Connection for Counseling, Education, and Support (ACCESS) II

A NA study of HIV Infections, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04499781 is a NA study of HIV Infections that has completed, run by NYU Langone Health. The registered enrollment target is 60 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04499781, a NA study of HIV Infections, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the proposed clinical trial, Adherence Connection for Counseling, Education, and Support (ACCESS)-II, is to test the efficacy of ACCESS-II on antiretroviral treatment (ART) adherence and HIV-viral load in Black and Hispanic HIV-infected (HIV+) adolescents and young adults (AYA), ages 18-29 years (N=120) using a longitudinal (12 and 24 week outcomes), two-group, randomized control trial (RCT). Participants in the intervention condition will use videoconferencing to connect synchronously with trained HIV+ peer health coaches who will deliver eight weekly, 60-minute cognitive behavioral/motivational sessions for improved ART adherence. Participants in the control will connect asynchronously to a web-based HIV ART adherence education condition.

Conditions Studied

HIV Infections

Interventions

  • BEHAVIORAL ACCESS II mHealth Intervention
  • BEHAVIORAL ACCESS II control condition

Study Locations (1)

New York

  • Jacobi Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-02-14
Est. Completion 2024-07-25
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04499781

The ClinicalTrials.gov registry entry for NCT04499781 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (87% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which ACCESS II mHealth Intervention is the first listed.

NCT04499781 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04499781 about?

NCT04499781 is a clinical study titled "Adherence Connection for Counseling, Education, and Support (ACCESS) II". The primary objective of the proposed clinical trial, Adherence Connection for Counseling, Education, and Support (ACCESS)-II, is to test the efficacy of ACCESS-II on antiretroviral treatment (ART) adherence and HIV-viral load in Black and Hispanic HIV-infected (HIV+) adolescents and young adults (A...

What is the current status of trial NCT04499781?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-02-14. Estimated completion is 2024-07-25.

What conditions does trial NCT04499781 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT04499781?

The interventions under investigation include: ACCESS II mHealth Intervention (BEHAVIORAL), ACCESS II control condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT04499781?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04499781 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.